February 14, 2025 India's Glenmark Pharma misses profit estimates on weak North America sales India's Glenmark Pharmaceuticals reported third-quarter profit below estimates on Friday due to bleak ...

Glenmark Pharmaceuticals Inc. USA has acquired and launched Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose ...

Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on ...

Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch1 of Polyethylene Glycol 3350, Powder for ...

1 Glenmark's Clindamycin Phosphate Foam, 1% is only approved for the indication(s) listed in Glenmark's approved label. 2 All brand names and trademarks are the property of their respective owners.

Glenmark Pharma Share Price News: Mumbai-headquartered pharmaceuticals company Glenmark Pharma's shares are in the spotlight once again on Dalal Street.The company's US arm has released its injection ...

Glenmark Pharmaceuticals has introduced a new constipation treatment, polyethylene glycol 3350 powder, to the US market. This launch aims to fulfill the rising demand for a fresh supplier in the ...